Lung and bronchus cancer in women: A 21st-century epidemic

Clinical Obstetrics and Gynecology

Volumn 45, Issue 3, 2002, Pages 784-811

  Tewari, Krishnansu Sujata ^a   DiSaia, Philip John ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EDATREXATE; ETOPOSIDE; GEMCITABINE; IRINOTECAN; METHOTREXATE; NAVELBINE; PACLITAXEL; TOPOTECAN;

CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; DISEASE ASSOCIATION; EARLY DIAGNOSIS; HEALTH HAZARD; HISTOPATHOLOGY; HUMAN; LUNG CARCINOMA; MORTALITY; PREVALENCE; REVIEW; RISK FACTOR; THORAX RADIOGRAPHY;

BRONCHIAL NEOPLASMS; FEMALE; HISTORY, 15TH CENTURY; HISTORY, 16TH CENTURY; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; LUNG NEOPLASMS; SMOKING; WOMEN'S HEALTH;

EID: 0036405453     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200209000-00027     Document Type: Review

References (140)

1. Terry L. Smoking and health: The Surgeon General's Report, issued Jan. 11, 1964.
2. Detterbeck FC, Rivera MP, Socinski MA, Rosenman JG, eds. Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician. Philadelphia: WB Saunders, 2001.
3. Landis SH, Murray T, Bolden S, et al. Cancer statistics 1999. CA Cancer J Clin. 1999;49:8-31.
4. Wingo PA, Tong T, Bolden S. Cancer statistics. 1995. CA Cancer J Clin. 1995;45:8-30.
5. Schoolcraft HR. The sacred origin of tobacco. In: Historical and Statistical Information Respecting the Indian Tribes of the United States, 1851-1857, Philadelphia.
6. Corti C. A History of Smoking. Senate Press, 1931.
7. Braun J. A brief history of tobacco. Ukr Biokhim Zh. 1997;96:17-18.
8. Drake B. The European experience with native American tobacco. 1996.
9. Kluger R. Ashes to Ashes: America's Hundred-Year Cigarette War, the Public Health, and the Unabashed Triumph of Philip Morris. Vintage Books, 1997.
10. The American Tobacco Company. The American Tobacco Story. 1960.
11. Whelan, EM. Smoking Gun: How the Tobacco Industry Gets Away With Murder. Philadelphia: Stickley, 1984.
12. Hecht SS. Tobacco smoke carcinogens and lung cancer. JNCI. 1999;91:1194-1210.
13. Stedman RL. The chemical composition of tobacco and tobacco smoke. Chem Rev. 1968;2:153-207.
14. Smokeless (Spit) tobacco: A review of the state of the science. Proceedings of a Symposium during the 74th General Session of the International Association for Dental Research. Adv Dent Res. 1997;11:305-353.
15. Hoffman D, Hoffmann I. Significance of exposure to sidestream tobacco smoke. IARC Sci Publ. 1987;81:3-10.
16. Lesmes GR, Donofrio KH. Passive smoking: The medical and economic issues. Am J Med. 1992;93:38S-42S.
17. American Cancer Society. Report on the cancer-related health checkup: Cancer of the lung. CA Cancer J Clin. 1980;30:199-207.
18. Hayata Y, Funatsu H, Kato H, et al. Results of lung cancer screening programs in Japan: Early detection and localization of lung tumors in high risk groups. In: Band PR, ed. Recent Results of Cancer Research. Heidelberg: Springer, 1982:179-186.
19. Nash PA, Morgan JM, Tomkins JG. South London Lung Cancer Study. Br Med J. 1968;2:715-721.
20. American Cancer Society/Veterans Administration Lung Cancer Screening Study Coordinating Committee. An evaluation of radiologic and cytologic screening for the early detection of lung cancer: A cooperative pilot study of the American Cancer Society and the Veterans Administration. Cancer Res. 1966;26:2083-2121.
21. Weiss W, Boucot KR. The Philadelphia Pulmonary Neoplasm Research Project: Early roentgenographic appearance of bronchogenic carcinoma. Arch Intern Med. 1974;134:306-311.
22. Early lung cancer detection: Summary and conclusions. Am Rev Respir Dis. 1984;130:565-570.
23. Schimizu N, Ando A, Teramoto S, et al. Outcome of patients with lung cancer detected via mass screening as compared to those presenting with symptoms. J Surg Oncol. 1992;50:7-11.
24. Salomaa E-R, Liippo K, Taylor P, et al. Prognosis of patients with lung cancer found in a single chest radiograph screening. Chest. 1998;114:1514-1518.
25. Satoh H, Ishikawa H, Yamashita YT, et al. Outcome of patients with lung cancer detected by mass screening versus presentation with symptoms. Anticancer Res. 1997;17:2293-2296.
26. Huhti E, Sutinen S, Reinilä A, et al. Lung cancer in a defined geographical area: History and histological types. Thorax. 1980;35:660-667.
27. Ferguson MK. Diagnosing and staging of non-small cell lung cancer. Hematol Oncol Clin North Am. 1990;4:1053-1068.
28. Frost JK, Feinstein AR, Higgins GA Jr, et al. Lung cancer: Perspectives and prospects (NIH Conference). Ann Intern Med. 1970;73:1003-1024.
29. Feinstein AR. Symptomatic patterns, biologic behavior, and prognosis in cancer of the lung. Ann Intern Med. 1964;61:27-43.
30. Quinn D, Gianlupi A, Broste S. The changing radiographic presentation of bronchogenic carcinoma with reference to cell types. Chest. 1996;110:1474-1479.
31. Byers TE, Vena JE, Rzepka TF. Predilection of lung cancer for the upper lobes: An epidemiologic inquiry. JNCI. 1984;72:1271-1275.
32. Rubins JB, Rubins HB. Temporal trends in the prevalence of malignancy in resected solitary pulmonary lesions. Chest. 1996;109;100-103.
33. Siegelman SS, Khouri NF, Leo FP, et al. Solitary pulmonary nodules: CT assessment. Radiology. 1986;160:307-312.
34. Zerhouni EA, Stitik FP, Siegelman SS, et al. CT of the pulmonary nodule: A cooperative study. Radiology. 1986;160:319-327.
35. Geddes DM. The natural history of lung cancer: A review based on rates of tumour growth. Br J Dis Chest. 1979;73:1-17.
36. Yankelevitz DF, Gupta R, Zhao B, et al. Small pulmonary nodules: Evaluation with repeat CT - Preliminary experience. Radiology. 1999;212:561-566.
37. Mehta AC, Marty JJ, Lee FYW. Sputum cytology. Clin Chest Med. 1993;14:69-85.
38. Matsuda M, Horai T, Nakamura S, et al. Bronchial brushing and bronchial biopsy: Comparison of diagnostic accuracy and cell typing reliability in lung cancer. Thorax. 1986;41:475-478.
39. Zavala DC. Diagnostic fiberoptic bronchoscopy. Chest. 1975;68:12-19.
40. Zarbo RJ, Fenoglio-Preiser CM. Interinstitutional database for comparison of performance in lung fine-needle aspiration cytology: A College of American Pathologists Q-Probe study of 5264 cases with histologic correlation. Arch Pathol Lab Med. 1992;116:463-470.
41. Hughes JMB. 18F-fluorodeoxyglucose PET scans in lung cancer. Thorax. 1996;51 (suppl 2):516-522.
42. Lowe VJ, Fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol. 1998;16:1075-1084.
43. Mack MJ, Hazelrigg SR, Landreneau RJ, et al. Thoracoscopy for the diagnosis of the indeterminate solitary pulmonary nodule. Ann Thorac Surg. 1993;56:825-832.
44. Mitruka S, Landreneau RJ, Mack MJ, et al. Diagnosing the indeterminate pulmonary nodule: Percutaneous biopsy versus thoracoscopy. Surgery. 1995;118:676-684.
45. Hazelrigg SR, Magee MJ, Cetindag IB. Video-assisted thoracic surgery for diagnosis of the solitary lung nodule. Chest Surg Clin North Am. 1998;8:763-774.
46. Russo L, Wiechmann RJ, Magovern JA, et al. Early chest tube removal after video-assisted thoracoscopic wedge resection of the lung. Ann Thorac Surg. 1998;66:1751-1754.
47. Mountain CF. A new international staging system for lung cancer. Chest. 1986;89 (suppl):225S-233S.
48. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997;111:1710-1717.
49. American Joint Commission for Cancer. AJCC Cancer Staging Handbook, 5th Ed. Philadelphia: Lippincott-Raven, 1998.
50. Naruke T. Significance of lymph node metastases I lung cancer. Semin Thorac Cardiovasc Surg. 1993;4:210-218.
51. Karnofsky DA, Bruchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM, ed. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949:199-205.
52. Zubrod CG, Schneiderman M, Frei E III, et al. Appraisal of methods for the study of chemotherapy in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis. 1960;11:7-33.
53. Carbone DP. The biology of lung cancer. Semin Oncol. 1997;24:388-401.
54. NSCLS: World Health Organization. International Classification of Diseases for Oncology, 1976. Geneva: WHO, 1976.
55. Conley YD, Cafoncelli AR, Khan JH, et al. Bronchial carcinoid tumor: Experience over 20 years. Am Surg. 1992;58:670-672.
56. Vadasz P, Palffy G, Egervary M, et al. Diagnosis and treatment of bronchial carcinoid tumors: Clinical and pathological review of 120 operated patients. Eur J Cardiothorac Surg. 1993;7:8-11.
57. North WG. Neuropeptide production by small cell carcinoma: Vasopressin and oxytocin as plasma markers of disease. J Clin Endocrinol Metab. 1991;73:1316-1320.
58. Mangin M, Webb AC, Dreyer BE, et al. Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy. PNAS USA. 1988;85:597-601.
59. Stewart MF, Crosby SR, Gibson S, et al. Small cell lung cancer cell lines secrete predominantly ACTH precursor peptides not ACTH. Br J Cancer. 1989;60:20-24.
60. van Oosterhout AG, van de Pol M, ten Velde GP, et al. Neurologic disorders in 203 consecutive patients with small cell lung cancer. Results of a longitudinal study. Cancer. 1996;77:1434-1441.
61. Pancoast HK. Superior pulmonary sulcus tumor: Tumor characterized by pain, Homer's syndrome, destruction of bone and atrophy of hand muscles. JAMA. 1932;99:1391-1396.
62. Cybulsky IJ, Bennet WF. Mediastinoscopy as a routine outpatient procedure. Ann Thorac Surg. 1994;58:176-178.
63. Landreneau RJ, Sugarbaker DJ, Mack MJ, et al. Wedge resection versus lobectomy for stage I (TI NO MO) non-small-cell lung cancer. J Thorac Cardiovasc Surg. 1997;113:691-700.
64. Keagy BA, Lores ME, Starek PJK, et al. Elective pulmonary lobectomy: Factors associated with morbidity and operative mortality. Ann Thorac Surg. 1985;40:349-352.
65. Wada H, Nakamura T, Nakamoto K, et al. Thirty-day operative mortality for thoracotomy in lung cancer. J Thorac Cardiovasc Surg. 1998;115:70-73.
66. Romano PS, Mark DH. Patient and hospital characteristics related to in-hospital mortality after lung cancer resection. Chest. 1992;101:1332-1337.
67. Silvestri GA, Handy J, Lackland D, et al. Specialists achieve better outcomes than generalists for lung cancer surgery. Chest. 1998;114:675-680.
68. Perez CA, Pajak TF, Rubin P, et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy: Report by the Radiation Therapy Oncology Group. Cancer. 1987;59:1874-1881.
69. Cox JD, Azarnia N, Byhardt RW, et al. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with <69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11. J Clin Oncol. 1990;8:1543-1555.
70. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109-122.
71. Hayman JA, Martel MK, Ten Haken RK, et al. Dose escalation in non-small cell lung cancer (NSCLC) using conformal 3-dimensional radiation therapy (C3DRT): Update of a phase I trial [abstract]. Proc ASCO. 1999;18:459a.
72. Green RA, Humphrey E, Close H, et al. Alkylating agents in bronchogenic carcinoma. Am J Med. 1969;46:516-525.
73. Splinter TAW. Introduction to the treatment of lung cancer. Semin Oncol. 1997;24(Suppl 12): S12-1-S12-5.
74. Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J. 1995;311:899-909.
75. Cohen MH, Matthews MJ. Small cell bronchogenic carcinoma: A distinct clinicopathologic entity. Semin Oncol. 1978;5:234-243.
76. Hirsch FR, Matthews MJ, Aisner S, et al. Histopathologic classification of small-cell lung cancer: Changing concepts and terminology. Cancer. 1988;62:973-977.
77. Aisner J, Alberto P, Britan J, et al. Role of chemotherapy in small cell lung cancer: A consensus report of the International Association for the Study of Lung Cancer workshop. Cancer Treat Rep. 1983;67:37-43.
78. Hansen HH. Management of small cell cancer of the lung. Lancet. 1992;339:846-849.
79. Splinter TAW. Chemotherapy of small cell lung cancer: Duration of treatment. Lung Cancer. 1989;5:186-195.
80. Bunn PA, van Zandwijk N, Pastorino U, et al. First Euro-American forum on lung cancer treatment: European School of Oncology. Eur J Cancer. 1994;30A:710-713.
81. Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992;327:1618-1624.
82. Baldini EH, Strauss GM. Women and lung cancer: Waiting to exhale. Chest. 1997;112:229S-234S.
83. Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1996. CA Cancer J Clin. 1996;46:5-29.
84. Reducing the Health Consequences of Smoking. 25 Years of Progress: A Report of the Surgeon General. Rockville, Md: US Department of Health and Human Services, Public Health Service, Office of Smoking and Health, 1989. DHHS publication No. (CDC) 89-8411.
85. Emster VL. Female lung cancer. Ann Rev Public Health. 1996;17:97-114.
86. Chollat-Traquet C. Women and Tobacco. Geneva: World Health Organization, 1992.
87. Pierce JP, Fiore MC, Novotny TE, et al. Trends in cigarette smoking in the United States: Projections to the year 2000. JAMA. 1989;26:61-65.
88. Damber LA, Larsson L-G. Smoking and lung cancer with special regard to type of smoking and type of cancer: A case-control study in north Sweden. Br J Cancer. 1986;53:673-681.
89. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: Examination of the evidence. JNCI. 1996;88:183-192.
90. Landis SH, Murray T, Bolden S, et al. Cancer statistics. 1999. CA Cancer J Clin. 1999;49:8-31.
91. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics 2000. CA Cancer J Clin 2000;50:7-33.
92. Brown CC, Kessler LG. Projections of lung cancer mortality in the United States: 1985-2025. JNCI. 1988;80:43-51.
93. Rozenberg S, Ham H. Fellow gynaecologists, help your patients stop smoking! Eur J Obstet Gynecol Reprod Biol. 2001;96:35-36.
94. World Health Organization. Annual Report, 1999.
95. Payne S. Smoke like a man, die like a man? A review of the relationship between gender, sex and lung cancer. Soc Sci Med. 2001;53:1067-1080.
96. Yang G, Fan L, Tan J, et al. Smoking in China: Findings of the 1996 prevalence survey. JAMA. 1999;282:1247-1253.
97. Pandey M, Matthew A, Nair MK. Global perspective of tobacco habits and lung cancer: A lesson for third world countries. Eur J Cancer Prev. 1999;8:271-279.
98. Andrews JL, Bloom S, Balogh K, et al. Lung cancer in women, Lahey Clinic experience, 1957-1980. Cancer. 1985;55:2894-2898.
99. Silverberg E, Grant RN. Cancer statistics, 1970. CA Cancer J Clin. 1970;20:10-23.
100. Silverberg E. Cancer statistics, 1980. CA Cancer J Clin. 1980;30:23-28.
101. Silverberg E, Boring CC, Squires TS. Cancer statistics, 1990. CA Cancer J Clin. 1990;40:9-27.
102. Horwitz RI, Smaldone LF, Viscoli CM. An ecogenetic hypothesis for lung cancer in women. Arch Intern Med. 1988;148:2609-2612.
103. Wu AH, Fontham ET, Reynolds P, et al. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol. 1995;141:1023-1032.
104. Alavanja MC, Brownson RC, Boice JD, et al. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol. 1992;136:623-632.
105. Menkes MS, Comstock GW, Vuilleumier JP, et al. Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med. 1986;315:1250-1254.
106. Steinmetz KA, Potter JD, Folsom AR. Vegetables, fruit, and lung cancer in the Iowa Women's Health Study. Cancer Res. 1993;53:536-543.
107. Wu AH, Henderson BE, Pike MC, et al. Smoking and other risk factors for lung cancer in women. JNCI. 1985;74:747-751.
108. Patterson WB, Emmanuel EJ. The eligibility of women for clinical research trials. J Clin Oncol. 1995;13:293-299.
109. Williams RR, Horm JW. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: Interview study from the Third National Cancer Survey. JNCI. 1977;58:525-547.
110. Risch HA, Howe GR, Jain M, et al. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol. 1993;138:281-293.
111. Harris RE, Zang EA, Anderson JI, et al. Race and sex differences in lung cancer risk associated with cigarette smoking. Int J Epidemiol. 1993;22:592-599.
112. Taioli E, Wynder EL. Re: Endocrine factors and adenocarcinoma of the lung in women. JNCI. 1994;86:869-870.
113. Henderson BE, Ross RK, Pike MC, et al. Endogenous hormones as a major factor in human cancer. Cancer Res. 1982;42:3232-3239.
114. Schoenberg JB, Wilcox HB, Mason TJ, et al. Variation in smoking-related lung cancer risk among New Jersey women. Am J Epidemiol. 1989;130:688-695.
115. Osann KE. Lung cancer in women: The importance of smoking, family history of cancer, and medical history of respiratory disease. Cancer Res. 1991;51:4893-4897.
116. Brownson RC, Loy TS, Ingram E, et al. Lung cancer in nonsmoking women. Cancer. 1995;75:29-33.
117. Osarm KE, Anton-Culver H, Kurosaki T, et al. Sex differences in lung cancer risk associated with cigarette smoking. Int J Cancer. 1993;54:44-48.
118. Brownson RC, Chang JL, Davis JR. Gender and histologic type variations in smoking-related risk of lung cancer. Epidemiology. 1992;3:61-64.
119. Hirayama S, Taminato T, Kitano N, et al. Non-smoking wives of heavy smokers have a higher risk of lung cancer: A study from Japan. Br Med J. 1981;282:183-185.
120. Capewell S, Sankaran R, Lamb D, et al. Lung cancer in lifelong non-smokers. Thorax. 1991;46:565-568.
121. Mitsudomi T, Tateishi M, Oka T, et al. Longer survival after resection of non-small cell lung cancer in Japanese women. Ann Thorac Surg. 1989;48:639-642.
122. Graham MV, Purdy JA, Emami B, et al. Preliminary results of a prospective trial using three-dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 1995;33:993-1000.
123. Albain KS, Rusch VW, Crowley JJ, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA(N2) and IIIB non-small cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol. 1995;13:1880-1992.
124. Bignall JR, Martin M. Survival experience of women with bronchial carcinoma. Lancet. 1972;2:60-62.
125. Harley HRS. Cancer of the lung in women. Thorax. 1976;31:254-264.
126. Kirsh MM, Tashian J, Sloan H. Carcinoma of the lung in women. Ann Thorac Surg. 1982;34:34-39.
127. Spiegelman D, Maurer LH, Ware JH, et al. Prognostic factors in small-cell carcinoma of the lung: An analysis of 1,521 patients. J Clin Oncol. 1989;7:344-354.
128. Skarin AT. Analysis of long-term survivors with small-cell lung cancer. Chest. 1993;103:440S-44S.
129. Fiore MC. Trends in cigarette smoking in the United States: The epidemiology of tobacco use. Med Clin North Am. 1992;76:289-303.
130. Nusbaum ML, Gordon M, Nusbaum D, et al. Smoke alarm: A review of the clinical impact of smoking on women. Prim Care Update Ob Gyn. 2000;7:207-214.
131. National Institute on Drug Abuse. Nicotine Addiction. Washington, DC: Department of Health and Human Services and National Institutes of Health, 1998. NIH Publication 98-4342.
132. Van Voorhis BJ, Dawson JD, Stovall DW, et al. The effects of smoking on ovarian function and fertility during assisted reproduction cycles. Obstet Gynecol. 1996;88:785-791.
133. Mattison DR, Plowchalk DR, Meadows MJ, et al. The effect of smoking on cogenesis, fertilization and implantation. Semin Reprod Endocrinol. 1989;7:291-304.
134. Fisher CL, Mannino DM, Herman WH, et al. Cigarette smoking and thyroid hormone levels in males. Int J Epidemiol. 1997;26:972-977.
135. Hammond EC. Smoking in relation to physical constraints. Arch Environ Health. 1961;3:28-46.
136. Fielding JE. Smoking and women: Tragedy of the majority. N Engl J Med. 1987;317:1343-1345.
137. Seltzer V. Cancer in women: Prevention and early detection. J Women's Health Gend Based Med. 2000;9:283-288.
138. Centers for Disease Control, Public Health Service, U.S. Department of Health and Human Services. The Health Benefits of Smoking Cessation. Washington, DC: US Govt Printing Office, 1990.
139. Albright CL, Altman DG, Slater MD, et al. Cigarette advertisements in magazines: Evidence for a differential focus on women's and youth magazines. Health Educ Q. 1988;2:225-233.
140. Warner KE, Goldenhar LM, McLaughlin CG. Cigarette advertising and magazine coverage of the hazards of smoking. N Engl J Med. 1992;2:305-309.